Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
March 24, 2016
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Use of Santyl Within an Accountable Care Organization
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
March 23, 2016
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Use of Santyl in Diabetic Foot Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
October 21, 2015
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
MEDIHONEY® Gel Versus Collagenase for Wound Debridement
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
June 26, 2015
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Santyl Applications to Diabetic Foot Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
April 11, 2014
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Newco Trials Pesquisa Científica Ltda
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
December 09, 2013
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Newco Trials Pesquisa Científica Ltda
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Total Occlusion Study in Coronary Arteries - 5
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
December 20, 2012
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Using Santyl or Bacitracin on Second Degree Burns
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
January 24, 2012
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Using Santyl on Diabetic Foot Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
August 03, 2011
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Collagenase Total Occlusion-1 Trial
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
January 06, 2011
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
